BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 12632033)

  • 1. Influence of soluble fibrin on reaction kinetics of plasmin type 1 and type 2 with alpha2-antiplasmin.
    Ries M; Zenker M
    Blood Coagul Fibrinolysis; 2003 Feb; 14(2):203-9. PubMed ID: 12632033
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Differences between neonates and adults in carbohydrate sequences and reaction kinetics of plasmin and alpha(2)-antiplasmin.
    Ries M; Easton RL; Longstaff C; Zenker M; Morris HR; Dell A; Gaffney PJ
    Thromb Res; 2002 Feb; 105(3):247-56. PubMed ID: 11927131
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serpin-serine protease binding kinetics: alpha 2-antiplasmin as a model inhibitor.
    Longstaff C; Gaffney PJ
    Biochemistry; 1991 Jan; 30(4):979-86. PubMed ID: 1703440
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Like fibrin, (DD)E, the major degradation product of crosslinked fibrin, protects plasmin from inhibition by alpha2-antiplasmin.
    Lee AY; Fredenburgh JC; Stewart RJ; Rischke JA; Weitz JI
    Thromb Haemost; 2001 Mar; 85(3):502-8. PubMed ID: 11307822
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lipoprotein (a) promotes plasmin inhibition by alpha 2-antiplasmin.
    Edelberg JM; Pizzo SV
    Biochem J; 1992 Aug; 286 ( Pt 1)(Pt 1):79-84. PubMed ID: 1381585
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antifibrinolytic activities of alpha-N-acetyl-L-lysine methyl ester, epsilon-aminocaproic acid, and tranexamic acid. Importance of kringle interactions and active site inhibition.
    Anonick PK; Vasudevan J; Gonias SL
    Arterioscler Thromb; 1992 Jun; 12(6):708-16. PubMed ID: 1375508
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Features of the interaction between alpha2-antiplasmin and plasminogen/plasmin].
    Hrynenko TV; Iusova OI; Zadorozhna MB; Makohonenko IeM
    Ukr Biokhim Zh (1999); 2002; 74(6):83-90. PubMed ID: 12924019
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of fibrin and alpha2-antiplasmin on plasminogen activation by staphylokinase.
    Okada K; Ueshima S; Takaishi T; Yuasa H; Fukao H; Matsuo O
    Am J Hematol; 1996 Nov; 53(3):151-7. PubMed ID: 8895684
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Regulation by alpha 2-antiplasmin and fibrin of the activation of plasminogen with recombinant staphylokinase in plasma.
    Silence K; Collen D; Lijnen HR
    Blood; 1993 Aug; 82(4):1175-83. PubMed ID: 7688990
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differences between neonates and adults in the urokinase-plasminogen activator (u-PA) pathway of the fibrinolytic system.
    Ries M; Zenker M; Gaffney PJ
    Thromb Res; 2000 Nov; 100(4):341-51. PubMed ID: 11113278
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fibrinogenolytic and fibrinolytic activity of cell-associated plasmin.
    Humphries JE; Vasudevan J; Gonias SL
    Arterioscler Thromb; 1993 Jan; 13(1):48-55. PubMed ID: 7678497
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Kinetics of the reactions between streptokinase, plasmin and alpha 2-antiplasmin.
    Cederholm-Williams SA; De Cock F; Lijnen HR; Collen D
    Eur J Biochem; 1979 Oct; 100(1):125-32. PubMed ID: 158524
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reaction of human alpha2-antiplasmin and plasmin stopped-flow fluorescence kinetics.
    Christensen U; Bangert K; Thorsen S
    FEBS Lett; 1996 May; 387(1):58-62. PubMed ID: 8654567
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Epsilon-aminocaproic acid promotes the release of alpha2-antiplasmin during and after cardiopulmonary bypass.
    Ray MJ; Hales M; Marsh N
    Blood Coagul Fibrinolysis; 2001 Mar; 12(2):129-35. PubMed ID: 11302475
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of alpha 2-plasmin inhibitor on plasminogen activation by staphylokinase/plasminogen complex.
    Okada K; Nonaka T; Matsumoto H; Fukao H; Ueshima S; Matsuo O
    Thromb Res; 1994 Oct; 76(2):211-20. PubMed ID: 7863470
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Soluble fibrin preparations inhibit the reaction of plasmin with alpha 2-macroglobulin. Comparison with alpha 2-antiplasmin and leupeptin.
    Anonick PK; Gonias SL
    Biochem J; 1991 Apr; 275 ( Pt 1)(Pt 1):53-9. PubMed ID: 1708234
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interaction between staphylokinase, plasmin(ogen), and alpha 2-antiplasmin. Recycling of staphylokinase after neutralization of the plasmin-staphylokinase complex by alpha 2-antiplasmin.
    Silence K; Collen D; Lijnen HR
    J Biol Chem; 1993 May; 268(13):9811-6. PubMed ID: 7683664
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The mechanism of activation of plasminogen at the fibrin surface by tissue-type plasminogen activator in a plasma milieu in vitro. Role of alpha 2-antiplasmin.
    Rouy D; Anglés-Cano E
    Biochem J; 1990 Oct; 271(1):51-7. PubMed ID: 1699517
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Activated thrombin-activatable fibrinolysis inhibitor reduces the ability of high molecular weight fibrin degradation products to protect plasmin from antiplasmin.
    Schneider M; Brufatto N; Neill E; Nesheim M
    J Biol Chem; 2004 Apr; 279(14):13340-5. PubMed ID: 14715654
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of a synthetic carboxy-terminal peptide of alpha(2)-antiplasmin on urokinase-induced fibrinolysis.
    Lee KN; Jackson KW; McKee PA
    Thromb Res; 2002 Feb; 105(3):263-70. PubMed ID: 11927133
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.